Patent US5817773A successfully refreshed from Google Patents.
US5817773A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Stimulation, production, culturing and transplantation of stem cells by fibroblast growth factors
Assignee: New York University
•
Filing: 1996-02-23
•
Granted: 1998-10-06
•
Expires: 2016-02-23
Abstract
Abstract Fibroblast growth factors are used in vivo, in situ and in vitro to stimulate stem cells, hemopoiesis, the immune system, transplant donor cells, culture and/or engraftment, wherein the use of fibroblast growth factors is disclosed for the stimulation of stem cells or hemopoietic cells, supporting cells and their progeny, in vitro, in situ and in vivo, as well as corresponding engrafting sites in vivo.
Inventors
- 👤 Elaine Lynette Wilson
- 👤 Janice Gabrilove
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 17:50
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0652; C12N5/0662; C12N5/0663; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1825; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/50; C07K14/503; C12N5/0618; C12N5/0623; A61K35/00; A61K35/12; A61K2035/124; C12N2501/00; C12N2501/10; C12N2501/11; C12N2501/115; C12N2501/125; C12N2501/15; C12N2501/20; C12N2501/22; C12N2501/30; C12N2501/38; C12N2501/39; C12N2501/90; C12N2501/91; C12N2502/00; C12N2502/13; C12N2502/1394
Claims Analysis
Total Claims: 41
Claim 1
Independent Claim
52 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal having a disease associated with dysplasia or aplasia of a bone marrow cell lineage, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor.
Claim 2
Independent Claim
52 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal having a disease associated with dysplasia or aplasia of a bone marrow cell lineage, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor.
Claim 3
Dependent Claim
35 words
A method according to claim 1, wherein said fibroblast growth factor is selected from the group consisting of basic fibroblast growth factor, acidic fibroblast growth factor, an hst/K-fgf gene product, FGF-6, KGF, FGF-5 and int-2.
Claim 4
Dependent Claim
11 words
A method according to claim 1, wherein said mammal is human.
Claim 5
Dependent Claim
35 words
A method according to claim 1, additionally comprising administering, in combination with said fibroblast growth factor, an amount of a heparin or a heparin analog effective to further stimulate proliferation of said hematopoietic progenitor cells.
Claim 6
Dependent Claim
17 words
A method according to claim 1, wherein said fibroblast growth factor is a basic fibroblast growth factor.
Claim 7
Dependent Claim
47 words
A method according to claim 5, wherein said basic fibroblast growth factor is selected from the group consisting of a 17.5 kilodalton, a 22.5 kilodalton, a 23.1 kilodalton, and a 24.2 kilodalton fragment of said fibroblast growth factor, as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Claim 8
Independent Claim
66 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal having a disease or condition requiring stimulation of the immune system of the mammal, whereby said administering step causes the immune response in said mammal to be enhanced, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor.
Claim 9
Independent Claim
66 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal having a disease or condition requiring stimulation of the immune system of the mammal, whereby said administering step causes the immune response in said mammal to be enhanced, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor.
Claim 10
Dependent Claim
35 words
A method according to claim 7, wherein said fibroblast growth factor is selected from the group consisting of basic fibroblast growth factor, acidic fibroblast growth factor, an hst/K-fgf gene product, FGF-6, KGF, FGF-5 and int-2.
Claim 11
Dependent Claim
17 words
A method according to claim 7, wherein said fibroblast growth factor is a basic fibroblast growth factor.
Claim 12
Dependent Claim
47 words
A method according to claim 9, wherein said basic fibroblast growth factor is selected from the group consisting of a 17.5 kilodalton, a 22.5 kilodalton, a 23.1 kilodalton, and a 24.2 kilodalton fragment of said fibroblast growth factor, as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Claim 13
Dependent Claim
11 words
A method according to claim 7, wherein said mammal is human.
Claim 14
Dependent Claim
35 words
A method according to claim 7, additionally comprising administering, in combination with said fibroblast growth factor, an amount of a heparin or a heparin analog effective to further stimulate proliferation of said hematopoietic progenitor cells.
Claim 15
Independent Claim
80 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal which is an intended donor of hematopoietic progenitor cells, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor, and, after said administering step, harvesting hematopoietic progenitor cells from said mammal at a time subsequent to said administration step sufficient to increase said production relative to the absence of administration of FGF.
Claim 16
Independent Claim
80 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, in a mammal which is an intended donor of hematopoietic progenitor cells, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor, and, after said administering step, harvesting hematopoietic progenitor cells from said mammal at a time subsequent to said administration step sufficient to increase said production relative to the absence of administration of FGF.
Claim 17
Dependent Claim
35 words
A method according to claim 13, wherein said fibroblast growth factor is selected from the group consisting of basic fibroblast growth factor, acidic fibroblast growth factor, an hst/K-fgf gene product, FGF-6, KGF, FGF-5 and int-2.
Claim 18
Dependent Claim
17 words
A method according to claim 13, wherein said fibroblast growth factor is a basic fibroblast growth factor.
Claim 19
Dependent Claim
47 words
A method according to claim 15, wherein said basic fibroblast growth factor is selected from the group consisting of a 17.5 kilodalton, a 22.5 kilodalton, a 23.1 kilodalton, and a 24.2 kilodalton fragment of said fibroblast growth factor, as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Claim 20
Dependent Claim
11 words
A method according to claim 13, wherein said mammal is human.
Claim 21
Dependent Claim
35 words
A method according to claim 13, additionally comprising administering, in combination with said fibroblast growth factor, an amount of a heparin or a heparin analog effective to further stimulate proliferation of said hematopoietic progenitor cells.
Claim 22
Dependent Claim
20 words
A method in accordance with claim 13, wherein said hematopoietic progenitor cells of said harvesting step are bone marrow cells.
Claim 23
Dependent Claim
26 words
A method in accordance with claim 13, wherein said hematopoietic progenitor cells of said harvesting step are obtained from the peripheral blood of said donor mammal.
Claim 24
Independent Claim
93 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells in a mammal which is an intended recipient of a transplant of hematopoietic progenitor cells, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor, and, after said administering step, engrafting hematopoietic progenitor cells into said mammal, wherein the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of a proliferation stimulating effective amount of an FGF.
Claim 25
Independent Claim
93 words
A method for stimulating proliferation, in vivo, of hematopoietic progenitor cells which are precursors of mature blood or lymph cells in a mammal which is an intended recipient of a transplant of hematopoietic progenitor cells, comprising administering to said mammal a proliferation stimulating effective amount of a fibroblast growth factor, and, after said administering step, engrafting hematopoietic progenitor cells into said mammal, wherein the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of a proliferation stimulating effective amount of an FGF.
Claim 26
Dependent Claim
20 words
A method in accordance with claim 21, wherein said hematopoietic progenitor cells of said engrafting step are bone marrow cells.
Claim 27
Dependent Claim
72 words
A method in accordance with claim 21, wherein said hematopoietic progenitor cells engrafted into said mammal are obtained by a method comprising administering to a donor mammal a proliferation stimulating effective amount of a fibroblast growth factor and harvesting hematopoietic growth cells from said donor mammal at a time subsequent to said step of administration to said donor mammal, sufficient to increase said production relative to the absence of administration of FGF.
Claim 28
Dependent Claim
16 words
A method according to claim 23, wherein said recipient mammal and said donor mammal are humans.
Claim 29
Dependent Claim
24 words
A method in accordance with claim 23, wherein said hematopoietic progenitor cells of said harvesting step and said engrafting step are bone marrow cells.
Claim 30
Dependent Claim
35 words
A method according to claim 21, wherein said fibroblast growth factor is selected from the group consisting of basic fibroblast growth factor, acidic fibroblast growth factor, an hst/K-fgf gene product, FGF-6, KGF, FGF-5 and int-2.
Claim 31
Dependent Claim
17 words
A method according to claim 21, wherein said fibroblast growth factor is a basic fibroblast growth factor.
Claim 32
Dependent Claim
47 words
A method according to claim 27, wherein said basic fibroblast growth factor is selected from the group consisting of a 17.5 kilodalton, a 22.5 kilodalton, a 23.1 kilodalton, and a 24.2 kilodalton fragment of said fibroblast growth factor, as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Claim 33
Dependent Claim
35 words
A method according to claim 21, additionally comprising administering, in combination with said fibroblast growth factor, an amount of a heparin or a heparin analog effective to further stimulate proliferation of said hematopoietic progenitor cells.
Claim 34
Independent Claim
49 words
A method for increasing, in a mammal, the concentration of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, comprising administering to said mammal an amount of a fibroblast growth factor which is effective to increase the concentration of said hematopoietic progenitor cells in said mammal.
Claim 35
Independent Claim
49 words
A method for increasing, in a mammal, the concentration of hematopoietic progenitor cells which are precursors of mature blood or lymph cells, comprising administering to said mammal an amount of a fibroblast growth factor which is effective to increase the concentration of said hematopoietic progenitor cells in said mammal.
Claim 36
Dependent Claim
77 words
In a method for harvesting from a mammal hematopoietic progenitor cells which are progenitors of mature blood or lymph cells, for the purpose of transplantation, comprising harvesting said hematopoietic progenitor cells from said mammal, the improvement, for stimulating the proliferation of said hematopoietic progenitor cells in said mammal prior to harvesting, comprising, prior to the harvesting of said hematopoietic progenitor cells, administering to said mammal a hematopoietic progenitor cell stimulating effective amount of a fibroblast growth factor.
Claim 37
Dependent Claim
77 words
In a method for harvesting from a mammal hematopoietic progenitor cells which are progenitors of mature blood or lymph cells, for the purpose of transplantation, comprising harvesting said hematopoietic progenitor cells from said mammal, the improvement, for stimulating the proliferation of said hematopoietic progenitor cells in said mammal prior to harvesting, comprising, prior to the harvesting of said hematopoietic progenitor cells, administering to said mammal a hematopoietic progenitor cell stimulating effective amount of a fibroblast growth factor.
Claim 38
Independent Claim
76 words
A method for transplanting into a mammal hematopoietic progenitor cells which are precursors of mature blood or lymph cells, comprising: (a) administering to said mammal an engraft stimulating effective amount of a fibroblast growth factor; and (b) engrafting said hematopoietic progenitor cells into said mammal, wherein the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of an engraft stimulating effective amount of an FGF.
Claim 39
Independent Claim
76 words
A method for transplanting into a mammal hematopoietic progenitor cells which are precursors of mature blood or lymph cells, comprising: (a) administering to said mammal an engraft stimulating effective amount of a fibroblast growth factor; and (b) engrafting said hematopoietic progenitor cells into said mammal, wherein the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of an engraft stimulating effective amount of an FGF.
Claim 40
Dependent Claim
82 words
In a method for transplanting hematopoietic progenitor cells which are progenitors of mature blood or lymph cells into a mammal, comprising engrafting said hematopoietic progenitor cells into said mammal, the improvement comprising administering to said mammal prior to said engrafting step, an engraft stimulating effective amount of a fibroblast growth factor, whereby the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of an engraft stimulating effective amount of an FGF.
Claim 41
Dependent Claim
82 words
In a method for transplanting hematopoietic progenitor cells which are progenitors of mature blood or lymph cells into a mammal, comprising engrafting said hematopoietic progenitor cells into said mammal, the improvement comprising administering to said mammal prior to said engrafting step, an engraft stimulating effective amount of a fibroblast growth factor, whereby the engraftment of said hematopoietic progenitor cells into said mammal is accelerated relative to engrafting said hematopoietic progenitor cells without administration of an engraft stimulating effective amount of an FGF.
References Cited (Backward Citations)
US4296100A
Cited
US4378347A
Cited
US4642120A
Cited
US4785079A
Cited
EP0281822A2
Cited
WO1989000198A1
Cited
EP0320148A1
Cited
US4950483A
Cited
US5024841A
Cited
US5399493A
Cited
US5198356A
Cited
WO1991018620A1
Cited
WO1992011355A1
Cited
US5459058A
Cited
US5405772A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-10-05 | 2002-04-06 | 2002-10-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-10-05 | 2006-04-06 | 2006-10-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-10-05 | 2010-04-06 | 2010-10-06 | $7700.00 | Window Closed / Lapsed |